-

Shareholder Alert: Robbins LLP Announces K12 Inc. (LRN) is Being Sued for Misleading Shareholders

SAN DIEGO & HERNDON, Va.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a purchaser of K12 Inc. (NYSE:LRN) filed a class action complaint against the Company and its officers and directors for alleged violations of the Securities & Exchange Act of 1934 between April 27, 2020 and September 18, 2020. K12 is a technology-based education company that provides online content and educational services worldwide.

If you suffered a loss due to K12's misconduct, click here.

K12 Inc. (LRN) Misled Shareholders About its Ability to Support Online Learning During the Pandemic

According to the complaint, following the nationwide closure of schools due to COVID 19, K12 and its officers and directors disseminated false and misleading statements touting the viability of the Company's online platforms, cybersecurity protocols, preparedness for large volumes of students, and its ability to support and train students, parents, and teachers. Based on these misstatements, the price of K12 shares rose to an all-time high of $51.60 on August 5, 2020. In reality, however, K12 did not have the technological capabilities to support and service the massive increase in traffic on its website and learning platforms. When news of K12's deficiencies were revealed, the price of its stock began to decline. The stock fell 7% on August 27, 2020, when Miami-Dade County teachers reported K12's training was ineffective and "unacceptable." On September 3, after Miami-Dade County experienced significant technical difficulties and revealed that the superintendent never signed the $15.3 billion contract with K12, the stock fell over 10.5%. The stock fell another 11.5% on September 10, after the Miami-Dade County Public School Board voted to terminate its K12 contract. Finally, Beaufort County School District also terminated its contact with K12, causing the stock to decline nearly 5% on September 18, 2020.

If you purchased K12 Inc. (LRN) securities between April 27, 2020 and September 18, 2020, you have until January 19, 2021, to ask the court to appoint you lead plaintiff for the class.

Contact us to learn more:
Lauren Levi
(800) 350-6003
llevi@robbinsllp.com
Shareholder Information Form

Robbins LLP is a nationally recognized leader in shareholder rights law. To be notified if a class action against K12 Inc. settles or to receive free alerts about companies engaged in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Lauren Levi
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
llevi@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Stockholder Alert: Robbins LLP Informs Investors of the Flotek Industries, Inc. (FTK) Class Action

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Flotek Industries, Inc. (NYSE: FTK) securities between August 3, 2026 and August 17, 2026 (the "Class Period"). Flotek is an energy technology and services company.The complaint alleges that Flotek misled investors by failing to disclose the cancellation of its $400m Puerto Rican deal.Investors who suffered s...

Robbins LLP Encourages WSE Stockholders with Large Losses to Seek Counsel for the Securities Class Action Lawsuit Against Wise Group plc

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Wise Group plc (NASDAQ: WSE) securities between May 11, 2026 and July 23, 2026 (the "Class Period").The complaint alleges that Wise and certain of its senior executives violated the federal securities laws by making materially false and/or misleading statements regarding the Company's anti-money laundering compliance, a...

Robbins LLP Urges Investors of ARS Pharmaceuticals Inc. to Contact the Firm for Information About the SPRY Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds shareholders that a securities class action has been filed on behalf of all investors who purchased or otherwise acquired ARS Pharmaceuticals Inc. (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026 (the "Class Period"). ARS is a clinical stage biopharmaceutical company focused on the development and commercialization of neffy for needle-free intranasal delivery of epinephrine for emergency treatment of Type 1 allergic reactions, incl...
Back to Newsroom